Bill Text: IL HB4101 | 2023-2024 | 103rd General Assembly | Introduced

---

Bill Title: Amends the Industrial Hemp Act. Sets forth provisions concerning hemp extract for human consumption. Provides that hemp extract distributed or sold in violation of the provisions shall be considered adulterated or misbranded. Provides that each establishment distributing products consisting of or containing hemp extract intended for human consumption must be permitted as a hemp food establishment by the Department of Agriculture. Provides that hemp or hemp extract intended for ingestion must be manufactured by an approved source. Provides that hemp or hemp extract intended for inhalation must be manufactured by a source permitted to manufacture hemp or hemp extract intended for inhalation. Provides that hemp extract intended for human consumption may not be manufactured, processed, packaged, held, prepared, or sold under specified provisions. Provides that hemp extract intended for human consumption shall not contain a total delta-9 tetrahydrocannabinol concentration that exceeds 0.3%. Provides that products intended for human consumption shall be considered adulterated if contaminants are detected at levels greater than the limits listed in the provisions. Sets forth limits concerning contaminants prohibited in hemp cultivation or processing; residual solvent limits for ingestion or inhalation; metals limits; biological limits for ingestion or inhalation; mycotoxin limits; total combined yeast and mold limit; and cannabinoid limits. Sets forth provisions concerning hemp extracts labeling, disposal, and age limits. Provides that hemp or hemp extract products that do not meet the requirements of the provisions may not be sold in the State. Provides that violations of the provisions shall result in the imposition of stop-sale or stop-use orders, an administrative fine of up to $5,000 per violation, permit suspension, permit revocation, or any combination of those penalties. Provides that the sale of hemp extract intended for inhalation to persons under the age of 21 shall result in an administrative fine of $5,000 per occurrence. Defines terms. Makes other changes.

Spectrum: Partisan Bill (Democrat 5-0)

Status: (Introduced) 2023-05-19 - Referred to Rules Committee [HB4101 Detail]

Download: Illinois-2023-HB4101-Introduced.html

---

103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB4101 Introduced , by Rep. Cyril Nichols SYNOPSIS AS INTRODUCED:
505 ILCS 89/30 new
Amends the Industrial Hemp Act. Sets forth provisions concerning hemp extract for human consumption. Provides that hemp extract distributed or sold in violation of the provisions shall be considered adulterated or misbranded. Provides that each establishment distributing products consisting of or containing hemp extract intended for human consumption must be permitted as a hemp food establishment by the Department of Agriculture. Provides that hemp or hemp extract intended for ingestion must be manufactured by an approved source. Provides that hemp or hemp extract intended for inhalation must be manufactured by a source permitted to manufacture hemp or hemp extract intended for inhalation. Provides that hemp extract intended for human consumption may not be manufactured, processed, packaged, held, prepared, or sold under specified provisions. Provides that hemp extract intended for human consumption shall not contain a total delta-9 tetrahydrocannabinol concentration that exceeds 0.3%. Provides that products intended for human consumption shall be considered adulterated if contaminants are detected at levels greater than the limits listed in the provisions. Sets forth limits concerning contaminants prohibited in hemp cultivation or processing; residual solvent limits for ingestion or inhalation; metals limits; biological limits for ingestion or inhalation; mycotoxin limits; total combined yeast and mold limit; and cannabinoid limits. Sets forth provisions concerning hemp extracts labeling, disposal, and age limits. Provides that hemp or hemp extract products that do not meet the requirements of the provisions may not be sold in the State. Provides that violations of the provisions shall result in the imposition of stop-sale or stop-use orders, an administrative fine of up to $5,000 per violation, permit suspension, permit revocation, or any combination of those penalties. Provides that the sale of hemp extract intended for inhalation to persons under the age of 21 shall result in an administrative fine of $5,000 per occurrence. Defines terms. Makes other changes.
LRB103 32639 BMS 62306 b
A BILL FOR
HB4101 LRB103 32639 BMS 62306 b
AN ACT concerning agriculture.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Industrial Hemp Act is amended by adding
Section 30 as follows:
(505 ILCS 89/30 new)
Sec. 30. Hemp extract for human consumption.
(a) Definitions. As used in this Section:
"Approved source" means an establishment manufacturing
products consisting of or containing hemp extract intended for
ingestion that meets local, State, or federal regulatory food
safety or health standards from the jurisdiction of origin.
"Batch" or "lot" means the hemp extract produced during a
period of time under similar conditions and identified by a
specific code that allows traceability.
"Expiration date" means the month and year as determined
by the manufacturer, packer, or distributor on the basis of
tests or other information showing that the product, until
that date, under the conditions of handling, storage,
preparation, and use per label directions will, when consumed,
contain not less than the quantity of each ingredient as set
forth on its label.
"Hemp" means the plant Cannabis sativa L. and any part of

HB4101 - 2 - LRB103 32639 BMS 62306 b
that plant, including the seeds thereof, and all derivatives,
extracts, cannabinoids, isomers, acids, salts, or isomers
thereof, whether growing or not, that has a total delta-9
tetrahydrocannabinol concentration that does not exceed 0.3%
on a dry-weight basis.
"Hemp extract" means a substance of compound intended for
ingestion that is derived from or contains hemp and that does
not contain other controlled substances.
"Hemp food establishment" means an establishment as
defined in extracting, manufacturing, processing, packing,
holding, preparing, or selling hemp Extract intended for human
consumption at wholesale or retail.
"Hemp extract intended for human consumption" includes
products intended for human ingestion or human inhalation, but
does not include topical applications.
"Ingestion" means the process of consuming hemp extract
through the mouth, whether by swallowing into the
gastrointestinal system or through tissue absorption.
"Inhalation" means the process of consuming hemp extract
through the mouth or nasal passages into the respiratory
system.
"Manufacturing" means preparing or packaging products
consisting of or containing hemp extract intended for human
consumption.
"Processor" or "extractor" means the establishment that
removes the hemp extract oil from the hemp plant.

HB4101 - 3 - LRB103 32639 BMS 62306 b
"Self-service merchandising" means an open display of hemp
extract products to which the public has access without the
intervention of the vendor or a store employee.
"Total delta-9 tetrahydrocannabinol concentration" means
delta-9 tetrahydrocannabinol plus 0.877 x
tetrahydrocannabinolic acid.
"Vending machine" means any self-service device that, upon
completion of payment, dispenses hemp extract products without
the necessity of replenishing the device between each
operation.
(b) Hemp extract distributed or sold in violation of this
Section shall be considered adulterated or misbranded. Hemp
extract intended for human consumption that is not clearly
labeled as intended for inhalation or ingestion must meet all
of the requirements for hemp products intended for both
inhalation and ingestion. If there are different requirements
for hemp products intended for inhalation and hemp products
intended for ingestion, the stricter standard shall apply.
(c) Each establishment distributing products consisting of
or containing hemp extract intended for human consumption must
be permitted as a hemp food establishment by the Department.
The annual permit fee for a hemp food establishment is
$650.00.
(d) Hemp or hemp extract intended for ingestion must be
manufactured by an approved source. A hemp food establishment
shall provide a valid hemp food establishment permit and the

HB4101 - 4 - LRB103 32639 BMS 62306 b
most recent food safety or health inspection report from the
approved source to the Department upon request.
(e) Hemp or hemp extract intended for inhalation must be
manufactured by a source permitted to manufacture hemp or hemp
extract intended for inhalation. A hemp food establishment
shall provide a valid hemp food establishment permit and the
most recent inspection report from the permitting source to
the Department upon request.
(f) Hemp extract intended for human consumption may not be
manufactured, processed, packaged, held, prepared, or sold
under Section 4 of the Food Handling Regulation Enforcement
Act.
(g) Hemp extract intended for human consumption must be
packaged in containers minimizing the exposure to light to
prevent degradation of the cannabinoids. Containers used for
hemp extract intended for human consumption must comply with
this requirement.
(h) Hemp extract intended for human consumption shall not
contain a total delta-9 tetrahydrocannabinol concentration
that exceeds 0.3%.
(i) Hemp extract intended for human consumption shall not
be manufactured, processed, packaged, held, or prepared in a
private home or in a room used as living or sleeping quarters.
(j) Hemp extract intended for human consumption shall not
be offered for sale by means of vending machines.
(k) Products intended for human consumption shall be

HB4101 - 5 - LRB103 32639 BMS 62306 b
considered adulterated if contaminants are detected at levels
greater than the limits listed in this Section. Contaminant
limits under this Section do not constitute authorization to
use or apply any of the following contaminants during hemp
cultivation or processing.
(1) The following substances are prohibited in Hemp
extract intended for inhalation:
(A) Abamectin, 300 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(B) Acephate, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(C) Acequinocyl, 2,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(D) Acetamiprid, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(E) Aldicarb, 100 parts per billion for Ingestion
or Inhalation.
(F) Azoxystrobin, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(G) Bifenazate, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(H) Bifenthrin, 500 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(I) Boscalid, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(J) Captan, 3,000 parts per billion for Ingestion;

HB4101 - 6 - LRB103 32639 BMS 62306 b
700 parts per billion for Inhalation.
(K) Carbaryl, 500 parts per billion for Ingestion;
500 parts per billion for Inhalation.
(L) Carbofuran, 100 parts per billion for
Ingestion or Inhalation.
(M) Chlorantraniliprole, 3,000 parts per billion
for Ingestion; 1,000 parts per billion for Inhalation.
(N) Chlordane, 100 parts per billion for Ingestion
or Inhalation.
(O) Chlorfenapyr, 100 parts per billion for
Ingestion or Inhalation.
(P) Chlormequat chloride, 3,000 parts per billion
for Ingestion; 1,000 parts per billion for Inhalation.
(Q) Chlorpyrifos, 100 parts per billion for
Ingestion or Inhalation.
(R) Clofentezine, 500 parts per billion for
Ingestion; 200 parts per billion for Inhalation.
(S) Coumaphos, 100 parts per billion for Ingestion
or Inhalation.
(T) Cyfluthrin, 1,000 parts per billion for
Ingestion; 500 parts per billion for Inhalation.
(U) Cypermethrin, 1,000 parts per billion for
Ingestion; 500 parts per billion for Inhalation.
(V) Daminozide, 100 parts per billion for
Ingestion or Inhalation.
(W) DDVP (Dichlorvos), 100 parts per billion for

HB4101 - 7 - LRB103 32639 BMS 62306 b
Ingestion or Inhalation.
(X) Diazinon, 200 parts per billion for Ingestion;
100 parts per billion for Inhalation.
(Y) Dimethoate, 100 parts per billion for
Ingestion or Inhalation.
(Z) Dimethomorph, 3,000 parts per billion for
Ingestion; 200 parts per billion for Inhalation.
(AA) Ethoprop(hos), 100 parts per billion for
Ingestion or Inhalation.
(BB) Etofenprox, 100 parts per billion for
Ingestion or Inhalation.
(CC) Etoxazole, 1,500 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(DD) Fenhexamid, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(EE) Fenoxycarb, 100 parts per billion for
Ingestion or Inhalation.
(FF) Fenpyroximate, 2,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(GG) Fipronil, 100 parts per billion for Ingestion
or Inhalation.
(HH) Flonicamid, 2,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(II) Fludioxonil, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(JJ) Hexythiazox, 2,000 parts per billion for

HB4101 - 8 - LRB103 32639 BMS 62306 b
Ingestion; 100 parts per billion for Inhalation.
(KK) Imazalil, 100 parts per billion for Ingestion
or Inhalation.
(LL) Imidacloprid, 3,000 parts per billion for
Ingestion; 400 parts per billion for Inhalation.
(MM) Kresoxim-methyl, 1,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(NN) Malathion, 2,000 parts per billion for
Ingestion; 200 parts per billion for Inhalation.
(OO) Metalaxyl, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(PP) Methiocarb, 100 parts per billion for
Ingestion or Inhalation.
(QQ) Methomyl, 100 parts per billion for Ingestion
or Inhalation.
(RR) Methyl parathion, 100 parts per billion for
Ingestion or Inhalation.
(SS) Mevinphos, 100 parts per billion for
Ingestion or Inhalation.
(TT) Myclobutanil, 3,000 parts per billion for
Ingestion; prohibited at any concentration for
Inhalation.
(UU) Naled, 500 parts per billion for Ingestion;
250 parts per billion for Inhalation.
(VV) Oxamyl, 500 parts per billion for Ingestion
or Inhalation.

HB4101 - 9 - LRB103 32639 BMS 62306 b
(WW) Paclobutrazol, 100 parts per billion for
Ingestion or Inhalation.
(XX) Pentachloronitrobenzene, 200 parts per
billion for Ingestion; 150 parts per billion for
Inhalation.
(YY) Permethrin, 1,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(ZZ) Phosmet, 200 parts per billion for Ingestion;
100 parts per billion for Inhalation.
(AAA) Piperonyl butoxide, 3,000 parts per billion
for Ingestion or Inhalation.
(BBB) Prallethrin, 400 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(CCC) Propiconazole, 1,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(DDD) Propoxur, 100 parts per billion for
Ingestion or Inhalation.
(EEE) Pyrethrins, 1,000 parts per billion for
Ingestion; 500 parts per billion for Inhalation.
(FFF) Pyridaben, 3,000 parts per billion for
Ingestion; 200 parts per billion for Inhalation.
(GGG) Spinetoram, 3,000 parts per billion for
Ingestion; 200 parts per billion for Inhalation.
(HHH) Spinosad A & D, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(III) Spiromesifen, 3,000 parts per billion for

HB4101 - 10 - LRB103 32639 BMS 62306 b
Ingestion; 100 parts per billion for Inhalation.
(JJJ) Spirotetramat, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(KKK) Spiroxamine, 100 parts per billion for
Ingestion or Inhalation.
(LLL) Tebuconazole, 1,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(MMM) Thiacloprid, 100 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(NNN) Thiamethoxam, 1,000 parts per billion for
Ingestion; 500 parts per billion for Inhalation.
(OOO) Trifloxystrobin, 3,000 parts per billion for
Ingestion; 100 parts per billion for Inhalation.
(3) Residual solvent limits for ingestion or
inhalation:
(A) 1,2-Dichloroethane, 2 parts per million.
(B) 1,1-Dichloroethene, 8 parts per million.
(C) Acetone, 750 parts per million.
(D) Acetonitrile, 60 parts per million.
(E) Benzene, 1 part per million.
(F) Butane, 5,000 parts per million.
(G) Chloroform, 2 parts per million.
(H) Ethanol, 5,000 parts per million.
(I) Ethyl Acetate, 400 parts per million.
(J) Ethyl Ether, 500 parts per million.
(K) Ethylene Oxide, 5 parts per million.

HB4101 - 11 - LRB103 32639 BMS 62306 b
(L) Heptane, 5,000 parts per million.
(M) Hexane, 250 parts per million.
(N) Isopropyl Alcohol, 500 parts per million.
(O) Methanol, 250 parts per million.
(P) Methylene Chloride, 125 parts per million.
(Q) Pentane, 750 parts per million.
(R) Propane, 5,000 parts per million.
(S) Toluene, 150 parts per million.
(T) Trichloroethylene 25 parts per million.
(U) Xylenes, Total (ortho-, meta-, para-), 150
parts per million.
(4) Metals limits:
(A) Cadmium, 500 parts per billion for ingestion;
200 parts per billion for inhalation.
(B) Lead, 500 parts per billion for ingestion or
inhalation.
(C) Arsenic, 1,500 parts per billion for
ingestion; 200 parts per billion for inhalation.
(D) Mercury, 3,000 parts per billion for
ingestion; 200 parts per billion for inhalation.
(5) Biological limits for ingestion or inhalation:
(A) Shiga toxin-producing Escherichia coli (STEC
E. coli) and other pathogenic E. coli, 1 CFU per gram.
(B) Salmonella, 1 CFU per gram.
(C) Aspergillus niger, Aspergillus fumigatus,
Aspergillus flavus, Aspergillus terreus, 1 CFU per

HB4101 - 12 - LRB103 32639 BMS 62306 b
gram.
(6) Mycotoxin limits:
(A) Total Aflatoxin (B1, B2, G1, G2), 20 parts per
billion for ingestion or inhalation.
(B) Ochratoxin, 20 parts per billion for ingestion
or inhalation.
(7) Total combined yeast and mold limit: 100,000 CFU
per gram for ingestion or inhalation.
(8) Cannabinoid limits: total delta-9
tetrahydrocannabinol concentration shall not exceed 0.3%.
(9) If a testing sample is found to contain levels of
any pathogen, toxicant, residual solvent, metal, or
pesticide not enumerated in this Section or by State law,
then the hemp extract shall be considered adulterated.
(10) Devices used during the inhalation process must
not introduce contaminants over the limits listed in this
Section into the hemp extract product.
(l) Hemp extract intended for human consumption must be
labeled as follows:
(1) If cannabinoids are marketed, the number of
milligrams of each cannabinoid per serving and the
serving size must be declared on the label.
(2) The label and advertisement shall not contain
claims indicating the product is intended for
diagnosis, cure, mitigation, treatment, or prevention
of disease; and if such claims are included, then the

HB4101 - 13 - LRB103 32639 BMS 62306 b
product shall be considered misbranded.
(3) Hemp extract intended solely for inhalation
must be clearly labeled with the statement, "Not
Intended For Ingestion – Do Not Eat.".
(m) Disposal.
(1) Laboratory samples found to contain more than
a total delta-9 tetrahydrocannabinol concentration of
0.3% shall be disposed of.
(2) Hemp extract intended for human consumption
containing a total delta-9 tetrahydrocannabinol
concentration that exceeds 0.3% shall be detained.
Hemp extract intended for human consumption containing
a total delta-9 tetrahydrocannabinol concentration
that exceeds 0.3% that has been detained shall not be
further subdivided or renumbered such that the
integrity of the lot is not maintained. The
establishment shall not dispose of the hemp extract
intended for human consumption in any manner until
written permission is given by the Department or a
court of competent jurisdiction.
(3) Upon receipt of written permission by the
Department or a court of competent jurisdiction, the
hemp extract intended for human consumption shall be
disposed of in a manner approved by a court of
competent jurisdiction.
(n) Age limit for hemp extract intended for inhalation.

HB4101 - 14 - LRB103 32639 BMS 62306 b
(1) Any retailer that sells hemp extract intended
for inhalation shall post a clear and conspicuous sign
directly adjacent to the display of the product that
states the following: "THE SALE OF HEMP EXTRACT
INTENDED FOR INHALATION TO PERSONS UNDER THE AGE OF 21
IS PROHIBITED. PROOF OF AGE IS REQUIRED FOR
PURCHASE.".
(2) Hemp extract intended for inhalation may not
be mailed, shipped, or otherwise delivered to a
purchaser unless, before the delivery to the
purchaser, the hemp food establishment obtains
confirmation that the purchaser is 21 years of age or
older.
(3) Hemp food establishments shall require proof
of age from a purchaser of any product containing hemp
extract intended for inhalation before selling the
product to that person. Hemp food establishments shall
exercise diligence in the management and supervision
of their premises and in the supervision and training
of their employees to prevent the underage sale of
these products.
(4) Hemp extract intended for inhalation shall not
be offered for sale by means of self-service
merchandising unless proof of age has been verified
before allowing access to the self-service
merchandising.

HB4101 - 15 - LRB103 32639 BMS 62306 b
(5) The giving or sampling of hemp extract
intended for inhalation products by a hemp food
establishment to any person under the age of 21 is
prohibited.
(o) Penalties.
(1) Hemp or hemp extract products must meet the
requirements of this Section. Hemp or hemp extract
products that do not meet the requirements of this
Section or without the documentation required in this
Section may not be sold in this State.
(2) Violations of this Section shall result in the
imposition of stop-sale or stop-use orders, an
administrative fine of up to $5,000 per violation,
permit suspension, permit revocation, or any
combination of those penalties.
(3) The sale of hemp extract intended for
inhalation to persons under the age of 21 shall result
in an administrative fine of $5,000 per occurrence.